4//SEC Filing
XENOGEN CORP 4
Accession 0001181431-06-047234
CIK 0001116449operating
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 12:16 PM ET
Size
24.4 KB
Accession
0001181431-06-047234
Insider Transaction Report
Form 4
XENOGEN CORPXGEN
Abingworth Management LTD
10% Owner
Transactions
- Disposition to Issuer
Common Stock
2006-08-09−1,300,117→ 0 total(indirect: By Abingworth Bioventures III A L.P.) - Disposition to Issuer
Common Stock
2006-08-09−793,641→ 0 total(indirect: By Abingworth Bioventures III B L.P.) - Disposition to Issuer
Common Stock
2006-08-09−20,719→ 0 total(indirect: By Abingworth Bioventures III Executives L.P.) - Disposition to Issuer
Warrant (Right to Buy)
2006-08-09−129,381→ 0 total(indirect: By Abingworth Bioventures III A L.P.)Exercise: $3.29From: 2006-02-15Exp: 2010-08-15→ Common Stock (129,381 underlying) - Disposition to Issuer
Common Stock
2006-08-09−515,464→ 0 total(indirect: By Abingworth Bioequities Master Fund Limited) - Disposition to Issuer
Warrant (Right to Buy)
2006-08-09−2,062→ 0 total(indirect: By Abingworth Bioventures III Executives L.P.)Exercise: $3.29From: 2006-02-15Exp: 2010-08-15→ Common Stock (2,062 underlying) - Disposition to Issuer
Common Stock
2006-08-09−475,398→ 0 total(indirect: By Abingworth Bioventures III C L.P.) - Disposition to Issuer
Warrant (Right to Buy)
2006-08-09−47,309→ 0 total(indirect: By Abingworth Bioventures III C L.P.)Exercise: $3.29From: 2006-02-15Exp: 2010-08-15→ Common Stock (47,309 underlying) - Disposition to Issuer
Warrant (Right to Buy)
2006-08-09−154,639→ 0 total(indirect: By Abingworth Bioequities Master Fund Limited)Exercise: $3.29From: 2006-02-15Exp: 2010-08-15→ Common Stock (154,639 underlying) - Disposition to Issuer
Common Stock
2006-08-09−15,715→ 0 total(indirect: By Abingworth Ltd.) - Disposition to Issuer
Warrant (Right to Buy)
2006-08-09−78,979→ 0 total(indirect: By Abingworth Bioventures III B L.P.)Exercise: $3.29From: 2006-02-15Exp: 2010-08-15→ Common Stock (78,979 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to an Agreement and Plan of Merger between the Issuer, Caliper Life Sciences, Inc. ("Caliper") and Caliper Holdings, Inc. (the "Merger"). In exchange for each share of Issuer common stock, stockholders of the Issuer received .5792 shares of Caliper Common Stock, having a market value of $4.84 (the closing sale price) per share on the effective date of the Merger and a Warrant to purchase .2249 of a share of Caliper Common Stock.
- [F2]This warrant was assumed by Caliper in the Merger and replaced with a warrant to purchase .5792 shares of Caliper common stock for each Issuer warrant share at an exercise price of $4.84 (closing sale price) per share.
Documents
Issuer
XENOGEN CORP
CIK 0001116449
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001116449
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 12:16 PM ET
- Size
- 24.4 KB